PROCEPT BioRobotics Nov 18, 2026 Copy link PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026 SAN JOSE, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a Business
PROCEPT BioRobotics Nov 4, 2026 Copy link PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance SAN JOSE, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a Business
PROCEPT BioRobotics Oct 12, 2026 Copy link PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026 SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a Business
PROCEPT BioRobotics Aug 20, 2026 Copy link PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026 SAN JOSE, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a Business
PROCEPT BioRobotics Aug 19, 2026 Copy link PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results SAN JOSE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a Business
PROCEPT BioRobotics Jul 14, 2026 Copy link PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026 SAN JOSE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a Business
PROCEPT BioRobotics May 28, 2026 Copy link PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval SAN JOSE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones Business
PROCEPT BioRobotics Mar 23, 2026 Copy link EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH Updated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in Business